Top Markets
Coin of the day
Abingdon Health Plc Abingdon Health Plc

Abingdon Health Plc

ABDX
Rank in Stocks #39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Share Price
$0.14287366
Last synced: 2026-08-13
Market Cap
$361.12K
Change (1 day)
0.00%
Change (1 year)
68.97%
Country
GB
Trade Abingdon Health Plc (ABDX)

Category

P/S ratio for Abingdon Health Plc (ABDX)
P/S ratio as of 2026 TTM: 0
According to Abingdon Health Plc latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Abingdon Health Plc from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.61 -
US
5.46 -
US
- -
CN
15.33 -
US
9.92 -
US